What amount of guaifenesin ingestion is associated with serious adverse effects such as central nervous system depression and cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Guaifenesin Overdose: Specific Toxic Doses

There is no established toxic dose threshold for guaifenesin that reliably predicts CNS depression or cardiac arrest, but documented fatal cases have involved blood concentrations of 25-27 mg/L, which likely corresponds to massive ingestions of 20-40+ grams (100-200+ times the standard single dose).

Critical Context from Fatal Cases

The evidence base for guaifenesin toxicity is extremely limited, consisting primarily of isolated case reports rather than systematic dose-response data:

Documented Fatal Case

A 23-year-old woman died approximately 2 hours after guaifenesin ingestion with:

  • Femoral blood concentration: 25.0 μg/mL (25 mg/L)
  • Brain tissue: 17.0 μg/g
  • Liver: 25.0 μg/g
  • Clinical course: CNS depression → asystole 1

Second Fatal Case

A 48-year-old woman in a mixed overdose had:

  • Blood guaifenesin: 27.4 mg/L (highest reported concentration at that time)
  • Co-ingestion with diphenhydramine (8.8 mg/L) and chlorpheniramine (0.2 mg/L) 2

Estimating Ingested Amounts

Standard therapeutic dosing context:

  • Single dose: 200-400 mg
  • Maximum daily dose: 2400 mg 3

To achieve blood levels of 25-27 mg/L likely requires:

  • Estimated ingestion of 20-40+ grams (based on pharmacokinetic extrapolation)
  • This represents 50-100+ times the maximum daily therapeutic dose
  • Approximately 100-200 standard 200mg tablets

Critical Clinical Pitfalls

Detection Issues

Guaifenesin is NOT detected by standard toxicology screens and requires specific testing if suspected 1. This means:

  • Many overdoses may be missed entirely
  • The true incidence of serious toxicity is unknown
  • You must specifically request guaifenesin levels if suspected

Time Course

  • Onset of severe toxicity: As rapid as 2 hours post-ingestion 1
  • CNS depression precedes cardiovascular collapse
  • Progression can be swift once symptoms begin

Management Approach

Since no specific antidote exists and guaifenesin toxicity is not addressed in poisoning guidelines 4:

Supportive care is the cornerstone:

  • Aggressive airway management for CNS depression
  • Standard ACLS protocols for cardiac arrest
  • Contact poison control (1-800-222-1222) for any suspected massive ingestion 4

Key monitoring parameters:

  • Serial neurologic assessments
  • Continuous cardiac monitoring
  • Consider specific guaifenesin level testing if massive ingestion suspected

Bottom Line for Clinical Practice

Any intentional ingestion of >10-15 grams of guaifenesin (>50 standard tablets) should be considered potentially life-threatening and warrant aggressive monitoring and poison control consultation. However, the exact toxic threshold remains undefined due to the rarity of isolated guaifenesin overdoses and lack of systematic study. Most reported cases involve co-ingestions, making it difficult to attribute effects solely to guaifenesin 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.